13 employees
Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.
2016
$30M
from 3 investors over 3 rounds
Unicycive Therapeutics raised $30M on March 6, 2023
Investors: Logos Global Management, LP, Vivo Capital and RA Capital Management, L.P.